Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Medtronic plc logo
MDT
Medtronic plc
20:00:02
79.34 $
0.0000 (%0.00)
Previous Close: 78.14
Day Low₺78.45
Day High₺79.5
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

MDT: Medtronic plc Financials

Medtronic plc Income Statement

Total revenue
Net income
Gross margin TTM
65.02%
Operating margin TTM
17.78%
Net profit margin TTM
13.2%
Return on investment TTM
10%
Period end24/04/202630/04/202530/04/202430/04/2023
Total revenue36,364,000,00033,537,000,00032,364,000,00031,227,000,000
Operating income6,467,000,0005,955,000,0005,144,000,0005,485,000,000
Net income4,800,000,0004,662,000,0003,676,000,0003,758,000,000

All line items

Line item24/04/202630/04/202530/04/202430/04/2023
Total revenue36,364,000,00033,537,000,00032,364,000,00031,227,000,000
Cost of revenue12,721,000,00011,632,000,00011,216,000,00010,719,000,000
Gross profit23,643,000,00021,905,000,00021,148,000,00020,508,000,000
Research and development expenses2,873,000,0002,732,000,0002,735,000,0002,696,000,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses11,784,000,00010,849,000,00010,736,000,00010,415,000,000
Other expenses2,520,000,0002,369,000,0002,533,000,0001,912,000,000
Operating expenses17,179,000,00015,950,000,00016,004,000,00015,023,000,000
Cost and expenses29,900,000,00027,582,000,00027,220,000,00025,742,000,000
Net interest income-715,000,000-729,000,000-719,000,000-636,000,000
Interest income0000
Interest expense715,000,000729,000,000719,000,000636,000,000
Depreciation and amortization2,958,000,0002,861,000,0002,647,000,0002,697,000,000
EBITDA9,809,000,0009,218,000,0008,203,000,0008,697,000,000
EBIT6,851,000,0006,357,000,0005,556,000,0006,000,000,000
Non-operating income (excl. interest)-384,000,000-402,000,000-412,000,000-515,000,000
Operating income6,467,000,0005,955,000,0005,144,000,0005,485,000,000
Total other income/expenses (net)-331,000,000-327,000,000-307,000,000-121,000,000
Income before tax6,136,000,0005,628,000,0004,837,000,0005,364,000,000
Income tax expense1,299,000,000936,000,0001,133,000,0001,580,000,000
Net income from continuing operations4,837,000,0004,691,000,0003,704,000,0003,784,000,000
Net income from discontinued operations0000
Other adjustments to net income00-1,000,0000
Net income4,800,000,0004,662,000,0003,676,000,0003,758,000,000
Net income deductions0000
Bottom line net income4,800,000,0004,662,000,0003,676,000,0003,758,000,000
EPS4433
Diluted EPS4433
Weighted average shares outstanding1,281,800,0001,285,600,0001,327,700,0001,329,800,000
Weighted average diluted shares outstanding1,288,100,0001,289,900,0001,330,200,0001,332,800,000

Medtronic plc Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
25,590,000,000%
Total debt / assets MRQ
—
Period end25/04/202526/04/202428/04/202329/04/2022
Total assets91,680,000,00089,981,000,00090,948,000,00090,981,000,000
Total liabilities43,424,000,00039,561,000,00039,283,000,00038,259,000,000
Total equity48,024,000,00050,214,000,00051,483,000,00052,551,000,000

All line items

Line item25/04/202526/04/202428/04/202329/04/2022
Cash and cash equivalents2,218,000,0001,284,000,0001,543,000,0003,714,000,000
Short-term investments6,747,000,0006,721,000,0006,416,000,0006,859,000,000
Cash and short-term investments8,965,000,0008,005,000,0007,959,000,00010,573,000,000
Net receivables6,515,000,0006,128,000,0005,998,000,0005,551,000,000
Accounts receivable6,515,000,0006,128,000,0005,998,000,0005,551,000,000
Other receivables0000
Inventory5,476,000,0005,217,000,0005,293,000,0004,616,000,000
Prepaid expenses0000
Other current assets2,858,000,0002,585,000,0002,425,000,0002,319,000,000
Total current assets23,814,000,00021,935,000,00021,675,000,00023,059,000,000
Property, plant and equipment (net)6,837,000,0006,131,000,0005,569,000,0005,413,000,000
Goodwill41,737,000,00040,986,000,00041,425,000,00040,502,000,000
Intangible assets11,667,000,00013,225,000,00014,844,000,00015,594,000,000
Goodwill and intangible assets53,404,000,00054,211,000,00056,269,000,00056,096,000,000
Long-term investments0000
Tax assets0000
Other non-current assets7,624,000,0007,704,000,0007,436,000,0006,411,000,000
Total non-current assets67,865,000,00068,046,000,00069,274,000,00067,920,000,000
Other assets1,000,0000-1,000,0002,000,000
Total assets91,680,000,00089,981,000,00090,948,000,00090,981,000,000
Total payables3,807,000,0003,740,000,0003,502,000,0002,980,000,000
Accounts payable2,449,000,0002,410,000,0002,662,000,0002,276,000,000
Other payables1,358,000,0001,330,000,000840,000,000704,000,000
Accrued expenses3,683,000,0003,582,000,0003,581,000,0003,551,000,000
Short-term debt2,868,000,0001,086,000,00013,000,0003,736,000,000
Capital lease obligations (current)6,000,0006,000,0007,000,0006,000,000
Tax payables01,330,000,000840,000,000704,000,000
Deferred revenue0000
Other current liabilities2,515,000,0002,375,000,0001,948,000,0002,121,000,000
Total current liabilities12,879,000,00010,789,000,0009,051,000,00012,394,000,000
Long-term debt25,590,000,00023,877,000,00024,287,000,00020,316,000,000
Capital lease obligations (non-current)52,000,00055,000,00057,000,00056,000,000
Deferred revenue (non-current)0000
Deferred tax liabilities (non-current)403,000,000515,000,000708,000,000884,000,000
Other non-current liabilities4,500,000,0004,325,000,0005,180,000,0004,609,000,000
Total non-current liabilities30,545,000,00028,772,000,00030,232,000,00025,865,000,000
Other liabilities0000
Capital lease obligations58,000,00061,000,00064,000,00062,000,000
Total liabilities43,424,000,00039,561,000,00039,283,000,00038,259,000,000
Treasury stock0000
Preferred stock0000
Common stock0000
Retained earnings31,476,000,00030,403,000,00030,392,000,00030,250,000,000
Additional paid-in capital20,833,000,00023,129,000,00024,590,000,00024,566,000,000
Accumulated other comprehensive income/loss-4,284,000,000-3,318,000,000-3,499,000,000-2,265,000,000
Other stockholders' equity-1,000,000000
Total stockholders' equity48,024,000,00050,214,000,00051,483,000,00052,551,000,000
Total equity48,256,000,00050,420,000,00051,665,000,00052,722,000,000
Minority interest232,000,000206,000,000182,000,000171,000,000
Total liabilities and total equity91,680,000,00089,981,000,00090,948,000,00090,981,000,000
Total investments6,747,000,0006,721,000,0006,416,000,0006,859,000,000
Total debt28,516,000,00025,024,000,00024,364,000,00024,114,000,000
Net debt26,298,000,00023,740,000,00022,821,000,00020,400,000,000

Medtronic plc Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end24/04/202630/04/202530/04/202430/04/2023
Cash from operations7,330,000,0007,044,000,0006,787,000,0006,039,000,000
Cash from investing-2,934,000,000-1,937,000,000-2,366,000,000-3,493,000,000
Cash from financing-4,751,000,000-4,361,000,000-4,450,000,000-4,960,000,000
Net change in cash-269,000,000934,000,000-259,000,000-2,171,000,000

All line items

Line item24/04/202630/04/202530/04/202430/04/2023
Net income4,837,000,0004,691,000,0003,676,000,0003,784,000,000
Depreciation and amortization2,958,000,0002,861,000,0002,647,000,0002,697,000,000
Deferred income tax51,000,000-316,000,000-508,000,000-226,000,000
Stock-based compensation457,000,000429,000,000393,000,000355,000,000
Change in working capital-1,423,000,000-1,054,000,000-484,000,000-967,000,000
Accounts receivable-200,000,000-433,000,000-391,000,000-576,000,000
Inventory-404,000,000-292,000,000-139,000,000-939,000,000
Accounts payable46,000,000209,000,000391,000,000696,000,000
Other working capital-865,000,000-538,000,000-345,000,000-148,000,000
Other non-cash items450,000,000433,000,0001,063,000,000396,000,000
Net cash from operating activities7,330,000,0007,044,000,0006,787,000,0006,039,000,000
Investments in property, plant and equipment-1,904,000,000-1,859,000,000-1,587,000,000-1,459,000,000
Acquisitions (net)-406,000,000-98,000,000-211,000,000-1,867,000,000
Purchases of investments-8,725,000,000-8,226,000,000-7,748,000,000-7,514,000,000
Sales/maturities of investments8,105,000,0008,495,000,0007,441,000,0007,343,000,000
Other investing activities-4,000,000-249,000,000-261,000,0004,000,000
Net cash from investing activities-2,934,000,000-1,937,000,000-2,366,000,000-3,493,000,000
Net debt issuance-1,174,000,0002,139,000,0001,073,000,000-598,000,000
Long-term net debt issuance-1,183,000,0002,139,000,0001,073,000,000-603,000,000
Short-term net debt issuance9,000,000005,000,000
Net stock issuance-519,000,000-2,727,000,000-1,854,000,000-645,000,000
Net common stock issuance-519,000,000-2,727,000,000-1,854,000,000-337,000,000
Common stock issuance516,000,000508,000,000284,000,000308,000,000
Common stock repurchased-1,035,000,000-3,235,000,000-2,138,000,000-645,000,000
Net preferred stock issuance000-308,000,000
Net dividends paid-3,639,000,000-3,589,000,000-3,666,000,000-3,616,000,000
Common dividends paid-3,639,000,000-3,589,000,000-3,666,000,000-3,616,000,000
Preferred dividends paid0000
Other financing activities582,000,000-184,000,000-3,000,000-101,000,000
Net cash from financing activities-4,751,000,000-4,361,000,000-4,450,000,000-4,960,000,000
Effect of FX changes on cash85,000,000188,000,000-230,000,000243,000,000
Net change in cash-269,000,000934,000,000-259,000,000-2,171,000,000
Cash at end of period1,949,000,0002,218,000,0001,284,000,0001,543,000,000
Cash at beginning of period2,218,000,0001,284,000,0001,543,000,0003,714,000,000
Operating cash flow7,330,000,0007,044,000,0006,787,000,0006,039,000,000
Capital expenditure-1,904,000,000-1,859,000,000-1,587,000,000-1,459,000,000
Free cash flow5,426,000,0005,185,000,0005,200,000,0004,580,000,000
Income taxes paid1,942,000,0001,819,000,0001,622,000,0001,548,000,000
Interest paid774,000,000762,000,000826,000,000606,000,000